Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay
Completed · Not applicable
Conditions studied: Healthy
In brief
The study will identify healthy adults who have been vaccinated against pneumococcus, and collect blood for the purpose of developing laboratory assays.
Key facts
- Study ID
- NCT00508950
- Run by
- Pfizer
- People needed
- 152
- Starts
- 2007-08-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2016-08-17
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy adults 18-70 years of age
- Must have received 23vPS pneumococcal vaccine
You may not qualify if…
- Bleeding diathesis
- Pregnancy
- Chronic disease which could be worsened by donating blood
- Receipt of blood, blood products or immune globulin within six months
Where it is running
- Frontage Clinical Services Inc. — Secaucus, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.